A study for a 58 year old woman who takes Tamoxifen Citrate (an AI-powered real world drug study)

---

---

Number of reports submitted per year:

Information of the patient in this study:

• Age: 58
• Gender: female

---

Comparison with patient's specific adverse outcomes:

You can check what is more associated with an adverse outcome: a drug mix, a drug, a condition, or a population of certain gender and age. Each patient is different. It is not uncommon that the results can be inconclusive or insignificant.

By the same drug(s):

• Middle Insomnia (difficulty returning to sleep after awakening either in the middle of the night):
  - among females aged 58 (±5) who take the same drug: 0.05% (3 of 6,475)
  - among people who take the same drug, regardless of gender or age: 0.04% (14 of 34,825)

By each condition:

• people who have Middle Insomnia with Breast Cancer Stage I:
  - among females aged 58 (±5) who have Breast Cancer Stage I: 0% (0 of 142)
  - among people who have Breast Cancer Stage I, regardless of gender or age: 0% (0 of 628)

By each drug (FDA data only):

• people who take Tamoxifen Citrate and have Middle Insomnia:
  - among females aged 58 (±5) who take Tamoxifen Citrate and have side effects: 0.13% (3 of 2,264)
  - among people who take Tamoxifen Citrate and have side effects, regardless of gender or age: 0.13% (14 of 10,731)

Common side effects *:

1. Pain : 593 people, 9.16%
2. Fatigue (feeling of tiredness): 564 people, 8.71%
3. Stress And Anxiety : 538 people, 8.31%
4. Nausea (feeling of having an urge to vomit): 535 people, 8.26%
5. Hair Loss : 474 people, 7.32%
6. Malignant Neoplasm Progression (cancer tumour came back): 455 people, 7.03%
7. Joint Pain : 453 people, 7.00%
8. Weakness : 446 people, 6.89%
9. Metastases To Bone (cancer spreads to bone): 397 people, 6.13%
10. Dyspnea (difficult or laboured breathing): 358 people, 5.53%
11. Dizziness : 342 people, 5.28%
12. Bone Disorder : 339 people, 5.24%
13. Osteonecrosis Of Jaw (death of bone of jaw): 334 people, 5.16%
14. Headache (pain in head): 306 people, 4.73%
15. Back Pain : 302 people, 4.66%
16. Rashes (redness): 285 people, 4.40%
17. Anaemia (lack of blood): 284 people, 4.39%
18. Depression : 281 people, 4.34%
19. Diarrhea : 277 people, 4.28%
20. High Blood Pressure : 271 people, 4.19%

Common co-existing conditions *:

You may use this to check any potential undetected conditions.

1. Breast Cancer Metastatic : 547 people, 8.45%
2. High Blood Pressure : 278 people, 4.29%
3. Metastases To Bone (cancer spreads to bone): 259 people, 4.00%
4. Depression : 227 people, 3.51%
5. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 161 people, 2.49%
6. Pain : 152 people, 2.35%
7. Neoplasm Malignant (cancer tumour): 117 people, 1.81%
8. High Blood Cholesterol : 114 people, 1.76%
9. Stress And Anxiety : 113 people, 1.75%
10. Osteoporosis (bones weak and more likely to break): 111 people, 1.71%
11. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 99 people, 1.53%
12. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 89 people, 1.37%
13. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 88 people, 1.36%
14. Diabetes : 69 people, 1.07%
15. Hot Flush (sudden feelings of heat): 61 people, 0.94%
16. Insomnia (sleeplessness): 57 people, 0.88%
17. Breast Cancer Recurrent : 54 people, 0.83%
18. Asthma : 54 people, 0.83%
19. Arthritis (form of joint disorder that involves inflammation of one or more joints): 52 people, 0.80%
20. Type 2 Diabetes : 52 people, 0.80%

Common co-used drugs *:

You may use this to check any potential interacting drugs.

1. Arimidex (622 people, 9.61%)
2. Taxotere (610 people, 9.42%)
3. Zometa (578 people, 8.93%)
4. Femara (406 people, 6.27%)
5. Faslodex (373 people, 5.76%)
6. Herceptin (341 people, 5.27%)
7. Aredia (332 people, 5.13%)
8. Aromasin (312 people, 4.82%)
9. Xeloda (300 people, 4.63%)
10. Synthroid (294 people, 4.54%)
11. Letrozole (259 people, 4.00%)
12. Taxol (253 people, 3.91%)
13. Cyclophosphamide (244 people, 3.77%)
14. Ambien (232 people, 3.58%)
15. Calcium (219 people, 3.38%)
16. Cytoxan (216 people, 3.34%)
17. Fosamax (211 people, 3.26%)
18. Celebrex (200 people, 3.09%)
19. Nexium (196 people, 3.03%)
20. Dexamethasone (192 people, 2.97%)

Drug effectiveness *:

---